Sort
21,281 grants matching “influenza”
Development of highly potent human monoclonals for RSV immunoprophylaxis
$300,000Larry Zeitlin · Mapp Biopharmaceutical, Inc. · R43 · FY2018 · AI
PREPAREDNESS AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA IN ZAMBIA
$300,000Peter Mwaba · Ministry Of Health Zambia · U51 · FY2009 · IP
Novel anti-viral agents to treat influenza
$300,000Dipanwita Basu · Alexander Biodiscoveries, Llc · R43 · FY2010 · AI
Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes
$300,000Gretchen Jimenez · Molecular Express, Inc. · R43 · FY2012 · AI
Kansas City - New Vaccine Surveillance Network (KC-NVSN)
$300,000Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2018 · IP
PREPARENDNESS AND REPONSE TO AVIAN AND PANDEMIC INFLUENZA
$300,000Davy Chikamata · Ministry Of Health Zambia · U51 · FY2015 · IP
Cross-Protective Monoclonal Antibodies for treatment of pandemic Flu
$300,000Christopher H Clegg · Tria Bioscience Corporation · R43 · FY2012 · AI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2012 · AI
A universal influenza vaccine by dual-domain fusion with a novel carrier protein
$300,000Yawei Ni · Kj Biosciences, Llc · R43 · FY2011 · AI
Preparedness and Response to Avian and Pandemic Influenza in United Rep of Tanzan
$300,000Peter Langeni Mmbuji · Tanzania Ministry Of Health/Social Wlfre · U51 · FY2008 · IP
Development of a multimeric CD40 ligand vaccine adjuvant
$300,000Richard Syd Kornbluth · Multimeric Biotherapeutics, Inc. · R43 · FY2013 · AI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$300,000Kathy L Rowlen · Indevr, Inc. · R43 · FY2012 · AI
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination
$300,000Jason Graham Gall · Genvec, Inc. · R43 · FY2009 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$300,000Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2017 · IP
Human monoclonal antibodies for prevention of S. aureus infections
$300,000Barbara A Swanson · Sorrento Therapeutics, Inc. · R42 · FY2012 · AI
800 MHz Low Temperature Magic Angle Spinning NMR Probe.
$300,000Robert Guy Griffin · Massachusetts Institute Of Technology · S10 · FY2009 · RR
Collaborative Research: eMB: Next-generation phylodynamics: theory, algorithms, applications
$300,000Aaron A King · Regents Of The University Of Michigan - Ann Arbor · · FY2025 · MPS
SUSTAINING INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO SEASONAL
$300,000Gurgen Dumanyan · Armenia Ministry Of Health · U51 · FY2012 · IP
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$300,000Tom Kiedrzynski · Secretariat Of The Pacific Community · U50 · FY2006 · CI
Novel Vaccine Immunogens for Pandemic H5 Influenza
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2009 · AI
Dynamic Self-Assembly of Glycolipids for Unveiling Complex Glycan-Protein Interactions
$300,000Xiaoyang Zhu · Columbia University · · FY2013 · MPS
Dynamic Self-Assembly of Glycolipids for Unveiling Complex Glycan-Protein Interactions
$300,000Xiaoyang Zhu · University Of Texas At Austin · · FY2012 · MPS
Respiratory Panel Flow-Strip: a Point-of-Care Molecular Diagnostic Test
$300,000Christopher Gerard Cooney · Akonni Biosystems, Inc. · R43 · FY2012 · AI
Adjuvanted Influenza Vaccine
$300,000Peter Blackburn · Mercia Pharma, Inc. · R43 · FY2007 · AI
Rational Design of Live Attenuated Influenza A Vaccine Candidates
$300,000Eckard Wimmer · Codagenix, Inc. · R41 · FY2012 · AI